Clinical Trials Browser

Phase 2 × Riluzole × Clear all

Breast Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Sarcoma, Stomach Neoplasms, Urogenital Neoplasms, Colorectal Neoplasms

NCT06580002 2025-06-26

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

Phase 2 Recruiting

51 enrolled

BreastGastrointestinalGynecologicHead & NeckSarcomaThoracic

Breast Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Sarcoma, Stomach Neoplasms, Urogenital Neoplasms, Colorectal Neoplasms

NCT03722680 2025-04-23

RILUZOX-01

Phase 2 Suspended

80 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT00866840 2024-01-19

Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Phase 2 Completed

13 enrolled 11 charts

Dermatologic

Melanoma

Clinical Trials

Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

RILUZOX-01

Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery